Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications survival among metastatic colorectal cancer mcrc patients treated randomized controlled
… Causal Inference for Regulatory-Grade RWE Among the hurdles for making your healthcare interventions available to patients is being able to meet regulatory requirements for … approach starts by specifying the hypothetical pragmatic randomized trial (i.e. the “target trial”) that would answer …
… July 10, 2023 Guideline-Based Treatment Offers Greater Survival for Older Patients with Metastatic Breast Cancer Dr. Ravi Goyal, PhD, a senior … patients with HR+/HER2– metastatic breast cancer. Links to publications: Goyal RK, Chen H, Abughosh SM, Holmes HM, …
… of individual patient differences. In fact, by design, randomized clinical trials aim to factor out (through … medicine in any particular controlled group. However, some patients in your study will benefit more or less than the … uncover and understand heterogeneity in treatment response among your patients. These efficient methods allow patterns …
… the search and review and extracting results, our quality-controlled processes consistently ensure reliable and … responses including a mixture of binomial and ordinal data Survival outcomes Poisson outcomes including epidemiological …
… Evidence of Effective Treatment in Non-Small-Cell Lung Cancer with Capmatinib Share on: February 27, 2023 Non-small … and a high likelihood of brain metastases. Overall survival rates for patients with NSCLC with brain metastases are low. New …
… the characteristics and patterns of biomarker testing among patients in a real-world setting. Findings The findings … the recommended genetic testing in this population. Publications: Bhandari NR, Hess LM, Parikh RC, Sireci AN, … JA. Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the United States . …
… 2023 ESMO Breast Cancer Annual Congress Share on: Thursday, May 11 - … first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2− advanced breast cancer in … Real-world clinical outcomes among patients (pts) with metastatic/advanced triple-negative breast cancer (mTNBC) in …
… San Antonio Breast Cancer Symposium Share on: Tuesday, December 6 - Saturday, … Real-world treatment patterns and clinical outcomes in patients treated with Eribulin after prior PI3K inhibitor therapy for metastatic breast cancer. Goyal RK, Zhang J, Davis KL, …
… Identifying Patterns of Genetic Counseling Provided to Patients with BRCA Mutation Share on: May 4, 2021 Mutations in breast cancer susceptibility genes are known to increase the risk of … went on to note, "As genetic testing becomes more common among patients with cancer, it will be critically important …
… will be presented at the ESMO Congress 2023. Breast cancer specific survival (BCSS) in HR+/HER2- metastatic breast cancer (mBC) from 2010 to 2019. Brufsky A, …